ZNTL icon

Zentalis Pharmaceuticals
ZNTL

Overview Fund Activity

137 hedge funds and large institutions have $1.61B invested in Zentalis Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+3
Holders Change %
+2.24%
% of All Funds
2.18%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
17
Increased
52
Reduced
39
Closed
13
Calls
$4.81M
Puts
$906K
Net Calls
+$3.9M
Net Calls Change
+$541K

Top Buyers

1
EAM
1
Eventide Asset Management
Massachusetts
$157M
2
BlackRock
2
BlackRock
New York
$88.2M
3
SI
3
Sofinnova Investments
California
$24.3M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$105M
5
Millennium Management
5
Millennium Management
New York
$8.97M

Top Sellers

1
AllianceBernstein
1
AllianceBernstein
Tennessee
$1.16M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$190M
3
Goldman Sachs
3
Goldman Sachs
New York
$4.48M
4
State Street
4
State Street
Massachusetts
$54.2M
5
DTC
5
Deep Track Capital
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
5VM
26
5AM Venture Management
California
$9.83M – – –
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$9.72M +$2.21M +110,415 +30%
BC
28
Boxer Capital
California
$9.03M – – –
IHAM
29
Integral Health Asset Management
New York
$9.03M – – –
Millennium Management
30
Millennium Management
New York
$8.97M +$5.19M +258,600 +137%
Charles Schwab
31
Charles Schwab
California
$8.87M +$727K +36,219 +9%
SAM
32
Sectoral Asset Management
Quebec, Canada
$7.75M +$3.06M +152,525 +65%
Adage Capital Partners
33
Adage Capital Partners
Massachusetts
$6.05M -$5.08M -253,333 -46%
Renaissance Technologies
34
Renaissance Technologies
New York
$5.73M +$1.5M +75,000 +36%
Marshall Wace
35
Marshall Wace
United Kingdom
$5.43M -$4.92M -245,207 -48%
UBS AM
36
UBS AM
Illinois
$5M +$417K +20,777 +9%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$4.86M +$1.56M +77,572 +47%
Bank of America
38
Bank of America
North Carolina
$4.67M -$652K -32,521 -12%
Goldman Sachs
39
Goldman Sachs
New York
$4.48M -$10.2M -510,316 -70%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$4.03M -$1.01M -50,271 -20%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$3.91M – – –
MC
42
Mayo Clinic
Minnesota
$3.75M – – –
TD Asset Management
43
TD Asset Management
Ontario, Canada
$3.63M +$1.57M +78,140 +76%
Ameriprise
44
Ameriprise
Minnesota
$3.33M -$736K -36,675 -18%
Norges Bank
45
Norges Bank
Norway
$3.3M -$68.2K -3,400 -2%
KCM
46
Kennedy Capital Management
Missouri
$3.14M +$83.8K +4,178 +3%
SG Americas Securities
47
SG Americas Securities
New York
$2.94M +$1.46M +72,861 +99%
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$2.84M +$2.84M +141,388 New
Invesco
49
Invesco
Georgia
$2.74M +$126K +6,281 +5%
TC
50
TwinBeech Capital
New York
$2.58M +$2.58M +128,859 New
1
2
3 4 5